Orland Park, IL2 Active Studies

Ankylosing Spondylitis Clinical Trials in Orland Park, IL

Find 2 actively recruiting ankylosing spondylitis clinical trials in Orland Park, IL. Connect with local research sites and explore new treatment options.

2
Active Trials
2
Sponsors
102
Enrolling

Recruiting Ankylosing Spondylitis Studies in Orland Park

About Ankylosing Spondylitis Clinical Trials in Orland Park

Ankylosing spondylitis is a chronic inflammatory disease primarily affecting the spine and sacroiliac joints, causing pain, stiffness, and potentially spinal fusion. It typically begins in early adulthood. Treatment includes NSAIDs, biologics (TNF and IL-17 inhibitors), and physical therapy.

There are currently 2 ankylosing spondylitis clinical trials recruiting participants in Orland Park, IL. These studies are seeking a combined 102 participants. Research is being sponsored by National Cancer Institute (NCI), Dana-Farber Cancer Institute. Clinical trial participation is free and participants receive study-related medical care at no cost.

Ankylosing Spondylitis Clinical Trials in Orland Park — FAQ

Are there ankylosing spondylitis clinical trials in Orland Park?

Yes, there are 2 ankylosing spondylitis clinical trials currently recruiting in Orland Park, IL. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Orland Park?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Orland Park research site will contact you about next steps.

Are clinical trials in Orland Park free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Orland Park studies also compensate for your time and travel.

What ankylosing spondylitis treatments are being tested?

The 2 active trials in Orland Park are testing new therapies including novel drugs, biologics, and treatment approaches for ankylosing spondylitis.

Data updated March 2, 2026 from ClinicalTrials.gov